GLP -1 are great drugs for diabetic patients and certain metabolic diseases but they were being promoted as quick weight loss drugs for brides and grooms and this is unethical
Annals of the New York Academy of Sciences, 2004.
DOI: 10.1016/j.phrs.2022.106257 [Google Scholar] Liu QK
The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism
Despite how common GLP-1 use has become, there has been relatively little dermatology-focused research on their cutaneous side effects, with most of the existing literature limited to individual case reports. For the cross-sectional analysis, Fat and colleagues compared cutaneous adverse events reported in the FDA Adverse Event Reporting System (FAERS) for the GLP-1 receptor agonists semaglutide (Ozempic/ Wegovy, Novo Nordisk), liraglutide, exenatide and dulaglutide (Trulicity, Eli Lilly) with cutaneous adverse event reports for the dipeptidyl peptidase-4 (DPP-IV) inhibitors sitagliptin, saxagliptin, linagliptin and alogliptin

Evidence to Gather to File a Lawsuit Medical records Prescriptions Emergency room visits Consultations with specialists Doctors notes Expert testimony Proof of diagnosis Evidence of lost wages Recoverable Damages in a Lawsuit Against Trulicity Individuals with viable claims against the manufacturer of Trulicity, Eli Lilly, may be entitled to compensation for economic and non-economic losses